MONJUVI (tafasitamab-cxix) for injection

To get best price/cost of Raxone (idebenone) tablets in India, Call 9811747774 or Email [email protected] to discuss. To treat odiffuse large B-cell lymphoma (DLBCL).
MONJUVI (tafasitamab-cxix) for injection. FDA-Approved. To treat lymphoma
MONJUVI (tafasitamab-cxix) for injection price In Inida
Categories: , .

MONJUVI (tafasitamab-cxix) for injection. FDA-Approved. To treat lymphoma

What is FDA-approved MONJUVI (tafasitamab-cxix) for injection indicated for?

MONJUVI (tafasitamab-cxix) for injection is a prescription medicine. MONJUVI (tafasitamab-cxix) for injection is used to treat odiffuse large B-cell lymphoma (DLBCL).
INDICATIONS AND USAGE
MONJUVI is a CD19-directed cytolytic antibody indicated in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified,
including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT).
This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
DOSAGE FORMS & STRENGTHS
For injection: 200 mg of tafasitamab-cxix as lyophilized powder in singledose vial for reconstitution.
Manufactured By: MORPHOSYS US INC
Prescribing Information URL: Click Here

How to make an enquiry for MONJUVI (tafasitamab-cxix) for injection?

Anticancer medicine MONJUVI (tafasitamab-cxix) for injection available upon request. To get best price in india, Call 9811747774 or Email [email protected] to discuss advanced treatments with Blood Cancer Specialists in India without travel. Medvitaz Pharma Solutions can help you to get genuine, affordable and assurance of delivery of approved medicines for Blood Cancer.

Description

What Tafasitamab is indicated for?

Tafasitamab, sold under the brand name Monjuvi, is a medication used in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Tafasitamab may cause serious side effects including infusion related reactions, bone marrow suppression, infections, and harm to an unborn baby. The most common side effects of tafasitamab are low blood cell counts, fatigue, diarrhea, cough, fever, limb swelling, upper respiratory infection, and decreased appetite.

Tafasitamab is a humanized Fc-modified cytolytic CD19 antibody.

Tafasitamab was approved for medical use in the United States in July 2020. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.

How and where to buy MONJUVI (tafasitamab-cxix) for injection?

You can order MONJUVI (tafasitamab-cxix) for injection from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery of approved medicines for Blood Cancer. To get best price/cost of MONJUVI (tafasitamab-cxix) for injection in India, Call 8750295029 or Email [email protected]. FDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

Prev
Next
neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    Get Access to MONJUVI (tafasitamab-cxix) for injection In India

    Medvitaz Pharma is a Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer of Anti-Cancer Medicines / Drugs, used in Blood Cancer treatment from India. Submit the request form for cost price of Brand Name “MONJUVI (tafasitamab-cxix) for injection” or Generic Name “tafasitamab-cxix for injection
    ” can be imported for personal use under “patient name basis” treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Once we review your request and delivery process, we’ll send you an estimated price for the medicine within 1-2 days.

    You may be interested in

    DARZALEX (daratumumab) injection
    DARZALEX (daratumumab) injection, for intravenous use. Initial U.S. Approval – 2015
    ANDEXXA ® (coagulation factor Xa (recombinant), inactivated-zhzo). Lyophilized powder for solution for intravenous injection
    ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo). Lyophilized powder for solution for intravenous injection. Initial U.S. Approval: 2018
    COPIKTRA (duvelisib), capsules for oral use
    COPIKTRA (duvelisib), capsules for oral use. Initial U.S. Approval: 2018
    ALIQOPA ™ (copanlisib) for injection
    ALIQOPA (copanlisib) for injection, for intravenous use. Initial U.S. Approval: 2017
    CALQUENCE ® (acalabrutinib) capsules, for oral use
    CALQUENCE (acalabrutinib) capsules, for oral use. Initial U.S. Approval: 2017
    REVLIMID [lenalidomide] capsules
    REVLIMID [lenalidomide] capsules, for oral use. Initial US Approval: 2005